Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.
Mogenet
Ingrid
I
Simiand-Erdociain
Elise
E
Canonge
Jean-Marie
JM
Pris
Jacques
J
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008942:Mitoxantrone / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D013997:Time Factors
D000970:Antineoplastic Agents; D008942:Mitoxantrone